8-KThe WireStrategic
Exit / Disposal Costs · Company Update
Filed Dec 4, 2023 · 2y ago · Accession 0001438533-23-000050
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- 8-K
- Filing date
- Dec 4, 2023
- Report date
- Nov 30, 2023
- Document
- tvtx-20231130.htm
- Size
- 173 KB